Position history for BNP Paribas Asset Management Holding S.A.'s holdings in REGENERON PHARMACEUTICALS
BNP Paribas Asset Management Holding S.A. holds 273,120 shares of REGN (REGENERON PHARMACEUTICALS), worth $211M as of 2026-Q1. The position was increased (+10.8% shares). REGN represents 0.2% of BNP Paribas Asset Management Holding S.A.'s portfolio.
Current Value
$211M
Current Shares
273,120
Total Value Change
-$314.8M
Total Shares Change
-227,154
Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.
Increased |
| 273,120 |
+10.8% |
| $211M |
| 0.2% |
| $766.66 |
41 |
| 2025-Q4 | Increased | 246,476 | +5.0% | $190.3M | 0.2% | $773.94 | 38 |
| 2025-Q3 | Decreased | 234,832 | -46.7% | $132M | 0.3% | $560.05 | 0 |
| 2025-Q2 | Decreased | 440,424 | -17.3% | $231.2M | 0.6% | $519.56 | 0 |
| 2025-Q1 | Increased | 532,214 | +4.0% | $337.6M | 0.9% | $634.66 | 46 |
| 2024-Q4 | Increased | 511,556 | +5.3% | $364.4M | 0.9% | $698.71 | 46 |
| 2024-Q3 | Decreased | 485,847 | -2.9% | $510.7M | 1.3% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 500,274 | +23.8% | $525.8M | 1.4% | $1,045.23 | 60 |